Publications by authors named "Max Yano"

Claim this Profile
P
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.
Cecelia R Miller, Ying Huang, John N Allan, Seema A Bhat, David Bond, Max Yano

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Adam S Kittai, Ying Huang, Sarah Miller, John N Allan, Seema A Bhat, Max Yano

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond, Max Yano

Am J Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.
Max Yano, John C Byrd, Natarajan Muthusamy

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.
Max Yano, Chia Sharpe, J Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik

Blood Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL.
Max Yano, Jessica Nunes, Xiaokui Mo, Kerry A Rogers, Jennifer A Woyach

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.
Janek S Walker, Zachary A Hing, Steven Sher, James Cronin, Katie Williams, Max Yano

Nat Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
J T Greene, Rajeswaran Mani, Rahul Ramaswamy, Frank Frissora, Max Yano

Blood Adv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Rebecca Kohnken, Jing Wen, Bethany Mundy-Bosse, Kathleen McConnell, Ashleigh Keiter, Max Yano

Blood· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis